Potanin’s holding “Interros” withdraws from the shareholders of “Petrovax”
[ad_1]
The Interros holding, whose president is billionaire Vladimir Potanin, exits the Petrovax Pharm business and sells its entire pharmaceutical asset to the company’s management and VB Partners Ruben Vardanyan and Mikhail Broitman. About it reported on the company’s website. The transaction is financed by own and borrowed funds from a consortium of banks, its amount is not specified.
Sergey Batekhin, General Director of Interros, noted that the sale of Petrovax’s assets was an expected step, since the company has fulfilled all the conditions for cooperation in nine years, including large-scale investments aimed at the production of a wide range of new drugs over the past year.
Petrovax Pharm is a biopharmaceutical company founded in 1996, Russia’s largest exporter of original medicines and vaccines. The drugs are supplied to 12 countries of the European Union and the EAEU. The company cooperates with international pharmaceutical companies, including Pfizer, Abbott, Boehringer Ingelheim, ISU ABXIS.
[ad_2]
Source link
